Covered recipient · General Payments record
MONIKA FREELAND
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2020–2025
$1,492.03
- Reported across 33 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $886.63 | 19 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $740.03 | 18 |
| Insulet Corporation | $146.60 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Insulet Corporation | $146.60 | 09/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207116897 | CMS |
| Novo Nordisk Inc | $29.82 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188551718 | CMS |
| Novo Nordisk Inc | $8.80 | 03/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188776794 | CMS |
| Novo Nordisk Inc | $16.98 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188376832 | CMS |
| Novo Nordisk Inc | $21.34 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188788680 | CMS |
| Novo Nordisk Inc | $16.14 | 03/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188578850 | CMS |
| Novo Nordisk Inc | $21.66 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188232340 | CMS |
| Novo Nordisk Inc | $77.45 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188820004 | CMS |
| Novo Nordisk Inc | $61.25 | 04/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188842342 | CMS |
| Novo Nordisk Inc | $26.22 | 05/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188532306 | CMS |
| Novo Nordisk Inc | $89.03 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188730943 | CMS |
| Novo Nordisk Inc | $9.92 | 05/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189068283 | CMS |
| Novo Nordisk Inc | $14.40 | 06/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188826448 | CMS |
| Novo Nordisk Inc | $124.42 | 06/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188489413 | CMS |
| Novo Nordisk Inc | $84.33 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188761047 | CMS |
| Novo Nordisk Inc | $17.40 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189131279 | CMS |
| Novo Nordisk Inc | $90.73 | 09/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189092473 | CMS |
| Novo Nordisk Inc | $16.20 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188779186 | CMS |
| Novo Nordisk Inc | $13.94 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188221905 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.